Acceptance of Chemoprevention by Women at High Risk for Breast Cancer

被引：0
|
作者：
Lane, Karen [1 ]
Hyunh, Kelly [1 ]
Smith, Edie [1 ]
Hsiang, David [1 ]
Butler, John [1 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2010年 / 17卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [31] Chemoprevention Strategies for High Risk Women
    Toss, Angela
    Sebastiani, Federica
    Razzaboni, Elisabetta
    De Matteis, Elisabetta
    Marchi, Isabella
    Proietto, Manuela
    Cortesi, Laura
    CURRENT WOMENS HEALTH REVIEWS, 2012, 8 (01) : 86 - 93
  • [32] Women at high risk for breast cancer
    Gross, RE
    AMERICAN JOURNAL OF NURSING, 1998, 98 (04) : 55 - +
  • [33] Chemoprevention of breast cancer among women at elevated risk as defined by Gail Score
    Micallef, S.
    Micallef, D.
    Schembri-Wismayer, P.
    Brincat, M. P.
    Calleja-Agius, J.
    MINERVA GINECOLOGICA, 2015, 67 (04): : 335 - 352
  • [34] Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer
    Meiser, B
    Butow, P
    Price, M
    Bennett, B
    Berry, G
    Tucker, K
    Cuningham, K
    JOURNAL OF WOMENS HEALTH, 2003, 12 (08) : 769 - 778
  • [35] Women's interest in chemoprevention for breast cancer
    Bastian, LA
    Lipkus, IM
    Kuchibhatla, MN
    Weng, HH
    Halabi, S
    Ryan, PD
    Skinner, CS
    Rimer, BK
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) : 1639 - 1644
  • [36] Chemoprevention of breast cancer - Implications for postmenopausal women
    Fabian, CJ
    Kimler, BF
    DRUGS & AGING, 2002, 19 (01) : 43 - 78
  • [37] Budget Impact Analysis of Chemoprevention of Breast Cancer with Tamoxifen and Raloxifene among High-risk Women in Japan
    Kondo, Masahide
    Hoshi, Shu-Ling
    Toi, Masakazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (11) : 767 - 770
  • [38] Modeling the effect of tamoxifen chemoprevention on long-term mortality in white women at high risk of breast cancer
    Maucort-Boulch, Delphine
    Roy, Pascal
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2006, 15 (04) : 347 - 352
  • [39] Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: A cost-effectiveness analysis
    Hershman, D
    Sundararajan, V
    Jacobson, JS
    Heitjan, DF
    Neugut, AI
    Grann, VR
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 9 - 16
  • [40] A phase II breast cancer chemoprevention study of lovastatin in high-risk women: Initial feasibility data
    Kurian, A. W.
    Sharma, V. B.
    Schwartz, E. J.
    Mills, M. A.
    Staton, A. D.
    Chun, N. M.
    Kingham, K. E.
    Ford, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345